Ceridian HCM Stock Price, News & Analysis (NYSE:CDAY)

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM Holding Inc (NYSE:CDAY) released its quarterly earnings data on Tuesday, July, 30th. The company reported $0.12 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.07 by $0.05. The company had revenue of $196.30 million for the quarter, compared to analyst estimates of $192.29 million. Ceridian HCM had a return on equity of 2.34% and a net margin of 4.19%. The firm's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.44) earnings per share. View Ceridian HCM's Earnings History.

Ceridian HCM is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Ceridian HCM.

Ceridian HCM issued an update on its third quarter 2019 earnings guidance on Tuesday, July, 30th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $195-197 million, compared to the consensus revenue estimate of $198.68 million.

12 Wall Street analysts have issued 1-year target prices for Ceridian HCM's shares. Their predictions range from $37.00 to $65.00. On average, they expect Ceridian HCM's share price to reach $57.09 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price. View Analyst Price Targets for Ceridian HCM.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ceridian HCM.

Press coverage about CDAY stock has been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Ceridian HCM earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Ceridian HCM.

Ceridian HCM saw a drop in short interest in September. As of September 15th, there was short interest totalling 6,360,000 shares, a drop of 17.3% from the August 15th total of 7,690,000 shares. Based on an average trading volume of 967,700 shares, the short-interest ratio is presently 6.6 days. Approximately 7.3% of the company's stock are short sold. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Veeva Systems (VEEV), Synopsys (SNPS), ANSYS (ANSS), Cadence Design Systems (CDNS), Splunk (SPLK), Check Point Software Technologies (CHKP), Tableau Software (DATA), Symantec (SYMC), Atlassian (TEAM), Twilio (TWLO), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Citrix Systems (CTXS), SS&C Technologies (SSNC), Okta (OKTA) and Paycom Software (PAYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alteryx (AYX), CTR COAST MLP &/COM (CEN), Ferrellgas Partners (FGP), Costco Wholesale (COST), The Ultimate Software Group (ULTI), Five Below (FIVE), NVIDIA (NVDA), Union Pacific (UNP) and Adobe (ADBE).

(CDAY) raised $420 million in an initial public offering on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM's stock is owned by many different of institutional and retail investors. Top institutional investors include Zeke Capital Advisors LLC (0.01%), Strs Ohio (0.00%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%), Ingalls & Snyder LLC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View Institutional Ownership Trends for Ceridian HCM.

CDAY stock was bought by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, Zeke Capital Advisors LLC, Nelson Van Denburg & Campbell Wealth Management Group LLC, Strs Ohio and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $45.29.

Ceridian HCM has a market capitalization of $6.48 billion and generates $746.40 million in revenue each year. The company earns $-63,400,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Ceridian HCM employs 4,444 workers across the globe.View Additional Information About Ceridian HCM.

The official website for Ceridian HCM is http://www.ceridian.com/.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]